...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM webcast 9/12/2018

I just received a clarification from Sarah at IR. Webcast will not be available live, only archived. 

BearDownAZ 

Share
New Message
Please login to post a reply